We found that metformin plays a critical role in abrogating F. nucleatum-induced CRC chemoresistance in response to 5-Fu and oxaliplatin through the MYC/miR-361-5p cascade, and subsequently suppression of sonic hedgehog signaling and CRC cell stemness. Here, MYC is linked to colorectal carcinoma.